Table 4

Number of patients with abnormal ovarian screening test results and number of repeat tests among different risk groups

Risk group (Total no. pts)

No of pts with abnormal test result

No of repeat tests

Prophylactic BSO because of abnormal test

CA125 (%)

TVUS (%)

CA125 (%)

TVUS (%)

CA125

TVUS

High risk (397)

37* (9)

65* (16)

54 (14)

98 (25)

-

7

Moderate risk (112)

5 (4)

4 (4)

3** (3)

4 (6)

1

-

Low risk (36)

1 (3)

2 (6)

2 (6)

6 (17)

-

-

TVUS = transvaginal ultrasound; * includes 1 patient diagnosed with advanced ovarian cancer; ** no repeat tests in 2 patients: 1 patient with recurrent progressive breast cancer and 1 pregnant patient

Nobbenhuis et al. Hereditary Cancer in Clinical Practice 2011 9:11   doi:10.1186/1897-4287-9-11